FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2747028021> ?p ?o ?g. }

• W2747028021 endingPage "2064" @default.
• W2747028021 startingPage "2061" @default.
• W2747028021 abstract "Immune checkpoint inhibitors (ICIs) have significantly improved outcomes for patients with numerous cancers. However, these therapies are associated with immune-related adverse events (irAEs), which are inflammatory side effects potentially affecting any organ. Cases of ICI-induced inflammatory arthritis have also been reported. In general, mild irAEs are treated with corticosteroids, while tumour necrosis factor-α (TNFα) inhibitors are reserved for refractory cases. However, prolonged use of TNFα inhibitor (TNFαi) can induce widespread, significant immunosuppression, which can negatively impact the antitumour efficacy of ICI therapy. Therefore, in clinical scenarios where patients develop severe immunotherapy-induced irAEs, an unmet need exists for alternative therapeutic strategies that are effective and without immune dampening effects.The anti-interleukin (IL)-6 receptor antibody, tocilizumab, is a biological agent Food and Drug Administration approved for the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Here, we report on three patients who developed severe polyarthritis while receiving ICI therapy and were treated with tocilizumab. All three patients demonstrated significant clinical improvement; one patient maintained a durable antitumour response derived from checkpoint inhibition.These three cases suggest that anti-IL-6 receptor antibody may be an effective alternative to corticosteroids or TNFαi for the treatment of arthritis irAEs." @default.
• W2747028021 created "2017-08-31" @default.
• W2747028021 creator A5030834372 @default.
• W2747028021 creator A5033798832 @default.
• W2747028021 creator A5035245048 @default.
• W2747028021 creator A5035468368 @default.
• W2747028021 creator A5048082120 @default.
• W2747028021 creator A5057430055 @default.
• W2747028021 creator A5058653922 @default.
• W2747028021 creator A5065216794 @default.
• W2747028021 creator A5078173968 @default.
• W2747028021 date "2017-08-22" @default.
• W2747028021 modified "2023-10-18" @default.
• W2747028021 title "Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series" @default.
• W2747028021 cites W1594748719 @default.
• W2747028021 cites W1976841228 @default.
• W2747028021 cites W1981969796 @default.
• W2747028021 cites W1992094574 @default.
• W2747028021 cites W2028195000 @default.
• W2747028021 cites W2033009850 @default.
• W2747028021 cites W2045774880 @default.
• W2747028021 cites W2058487327 @default.
• W2747028021 cites W2064034345 @default.
• W2747028021 cites W2105057287 @default.
• W2747028021 cites W2148658155 @default.
• W2747028021 cites W2166662937 @default.
• W2747028021 cites W2209812019 @default.
• W2747028021 cites W2341285800 @default.
• W2747028021 cites W2441690768 @default.
• W2747028021 cites W2473218705 @default.
• W2747028021 cites W2487303921 @default.
• W2747028021 cites W2512614851 @default.
• W2747028021 cites W2600419100 @default.
• W2747028021 doi "https://doi.org/10.1136/annrheumdis-2017-211560" @default.
• W2747028021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28830882" @default.
• W2747028021 hasPublicationYear "2017" @default.
• W2747028021 type Work @default.
• W2747028021 sameAs 2747028021 @default.
• W2747028021 citedByCount "129" @default.
• W2747028021 countsByYear W27470280212017 @default.
• W2747028021 countsByYear W27470280212018 @default.
• W2747028021 countsByYear W27470280212019 @default.
• W2747028021 countsByYear W27470280212020 @default.
• W2747028021 countsByYear W27470280212021 @default.
• W2747028021 countsByYear W27470280212022 @default.
• W2747028021 countsByYear W27470280212023 @default.
• W2747028021 crossrefType "journal-article" @default.
• W2747028021 hasAuthorship W2747028021A5030834372 @default.
• W2747028021 hasAuthorship W2747028021A5033798832 @default.
• W2747028021 hasAuthorship W2747028021A5035245048 @default.
• W2747028021 hasAuthorship W2747028021A5035468368 @default.
• W2747028021 hasAuthorship W2747028021A5048082120 @default.
• W2747028021 hasAuthorship W2747028021A5057430055 @default.
• W2747028021 hasAuthorship W2747028021A5058653922 @default.
• W2747028021 hasAuthorship W2747028021A5065216794 @default.
• W2747028021 hasAuthorship W2747028021A5078173968 @default.
• W2747028021 hasConcept C126322002 @default.
• W2747028021 hasConcept C143998085 @default.
• W2747028021 hasConcept C17991360 @default.
• W2747028021 hasConcept C197934379 @default.
• W2747028021 hasConcept C203014093 @default.
• W2747028021 hasConcept C2777077863 @default.
• W2747028021 hasConcept C2777178219 @default.
• W2747028021 hasConcept C2777575956 @default.
• W2747028021 hasConcept C2777701055 @default.
• W2747028021 hasConcept C2778917330 @default.
• W2747028021 hasConcept C2780252810 @default.
• W2747028021 hasConcept C71924100 @default.
• W2747028021 hasConcept C8891405 @default.
• W2747028021 hasConceptScore W2747028021C126322002 @default.
• W2747028021 hasConceptScore W2747028021C143998085 @default.
• W2747028021 hasConceptScore W2747028021C17991360 @default.
• W2747028021 hasConceptScore W2747028021C197934379 @default.
• W2747028021 hasConceptScore W2747028021C203014093 @default.
• W2747028021 hasConceptScore W2747028021C2777077863 @default.
• W2747028021 hasConceptScore W2747028021C2777178219 @default.
• W2747028021 hasConceptScore W2747028021C2777575956 @default.
• W2747028021 hasConceptScore W2747028021C2777701055 @default.
• W2747028021 hasConceptScore W2747028021C2778917330 @default.
• W2747028021 hasConceptScore W2747028021C2780252810 @default.
• W2747028021 hasConceptScore W2747028021C71924100 @default.
• W2747028021 hasConceptScore W2747028021C8891405 @default.
• W2747028021 hasIssue "12" @default.
• W2747028021 hasLocation W27470280211 @default.
• W2747028021 hasLocation W27470280212 @default.
• W2747028021 hasOpenAccess W2747028021 @default.
• W2747028021 hasPrimaryLocation W27470280211 @default.
• W2747028021 hasRelatedWork W1551265647 @default.
• W2747028021 hasRelatedWork W2050078649 @default.
• W2747028021 hasRelatedWork W2076597215 @default.
• W2747028021 hasRelatedWork W2134133792 @default.
• W2747028021 hasRelatedWork W2136175148 @default.
• W2747028021 hasRelatedWork W2232273633 @default.
• W2747028021 hasRelatedWork W3009536542 @default.
• W2747028021 hasRelatedWork W3209686377 @default.
• W2747028021 hasRelatedWork W4284664836 @default.
• W2747028021 hasRelatedWork W4312185446 @default.
• W2747028021 hasVolume "76" @default.

• next